These included: Nausea (the most frequently reported adverse effect) Vomiting Diarrhoea Constipation Decreased appetite These effects were generally dose-dependent, occurring more frequently and with greater severity at higher doses
R., Jonsson, A., Pedersen, O., & Frch, K
Pritikin Program Lon Ben-Asher, Registered Dietitian and Pritikin Educator Prevent GI Side Effects Effective strategies to reduce gastrointestinal side-effects of GLP-1 drugs exist
Diabetes Care (2020) 43(6):13525
Polycystic Ovary Syndrome
The medicine is being marketed under the brand name Lirafit after receiving approval from the medicine Controller General of India (DCGI)